Bausch Health
BHC
NZ$10.36
Share price
0.00%
Change (1 day)
-5.73%
Change (1 year)
Categories
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.
Bausch Health (BHC) - Total assets
Total assets on the balance sheet as of March 2025 : NZ$44.29 Billion
According to Bausch Health 's latest financial reports the company's total assets are NZ$44.29 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Bausch Health - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | NZ$47.02 B | 8.74% |
| 2023-12-31 | NZ$43.24 B | 6.9% |
| 2022-12-31 | NZ$40.45 B | -5.37% |
| 2021-12-31 | NZ$42.75 B | -1.13% |
| 2020-12-31 | NZ$43.23 B | -14% |
| 2019-12-31 | NZ$50.28 B | 3.8% |
| 2018-12-31 | NZ$48.43 B | -8.25% |
| 2017-12-31 | NZ$52.79 B | -15.98% |
| 2016-12-31 | NZ$62.84 B | -12.16% |
| 2015-12-31 | NZ$71.54 B | 113.1% |
| 2014-12-31 | NZ$33.57 B | -1.37% |
| 2013-12-31 | NZ$34.03 B | 55.99% |
| 2012-12-31 | NZ$21.82 B | 29.92% |
| 2011-12-31 | NZ$16.79 B | 20.03% |
| 2010-12-31 | NZ$13.99 B | 393.53% |
| 2009-12-31 | NZ$2.83 B | 1.34% |
| 2008-12-31 | NZ$2.79 B | 20.25% |
| 2007-12-31 | NZ$2.32 B | -25.24% |
| 2006-12-31 | NZ$3.11 B | 4.85% |
| 2005-12-31 | NZ$2.96 B | 23.78% |
| 2004-12-31 | NZ$2.39 B | -32.16% |
| 2003-12-31 | NZ$3.53 B | 0.87% |
| 2002-12-31 | NZ$3.50 B | 9.28% |
| 2001-12-31 | NZ$3.20 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | NZ$30.46 M | -99.93% | 🇺🇸 USA |
 OPKO Health
OPK | NZ$3.56 B | -91.94% | 🇺🇸 USA |